Morepen Q2 FY27: CDMO revenue Rs. 253 Cr, first capacity phase completed at 614 KL
CDMO revenue rose to Rs. 253 Cr in Q2 FY27 from Rs. 58 Cr in Q1 FY27 as CDMO moved to commercial scale.
By ScoutQuest · · 1 min read
- Q2 EBITDA
- Rs. 132 Cr (up by 273 per cent)
- CDMO Revenue
- Rs. 253 Cr in Q2 FY27 from Rs. 58 Cr in Q1 FY27
- Medical Devices Revenue & Exports
- Medical Devices revenue rose 65 per cent to Rs. 208 Cr in Q2 FY27 and exports rose 131 per cent to Rs. 397 Cr
- Release
- Results press release
- Period
- Q2 FY27
_Consolidated · Q2 & H1 FY27_
📊 EBITDA, Q2 FY27: Rs. 132 Cr (up by 273 per cent)
🌍 Medical Devices revenue rose 65 per cent to Rs. 208 Cr in Q2 FY27 and exports rose 131 per cent to Rs. 397 Cr, the company reports.
🏭 H1 FY27 EBITDA reached Rs. 220 Cr, up 243 per cent, which Morepen says gives it a significantly stronger base to invest in capacity, capability and future growth.
📌 Execution of Morepen's previously announced Rs. 825 Cr global CDMO mandate is now in regular commercial supply, the company says.
Also from Morepen Laboratories
Designations of two senior management personnel changed on promotion, effective 27th October 2026
27 Oct 2026
Monitoring agency flags capex delay risk on QIP proceeds; Rs. 1.12 crore spent in Q2FY27
27 Oct 2026
Morepen Q2 FY27: revenue up 81% to Rs. 755 Cr, PAT up 117% as CDMO supplies scale up
27 Oct 2026
More numbers
- Revenue, Q2 FY27Rs. 755 Cr
- PAT, Q2 FY27Rs. 89 Cr
- Revenue, H1 FY27Rs. 1330 Cr
- PAT, H1 FY27Rs. 145 Cr
- EBITDA, Q2 FY27Rs. 132 Cr
- EBITDA margin, Q2 FY2717.45 per cent
- EBITDA, H1 FY27Rs. 220 Cr
- CDMO revenue, Q2 FY27Rs. 253 Cr
- CDMO revenue, Q1 FY27Rs. 58 Cr
- Medical Devices revenue, Q2 FY27Rs. 208 Cr
- Exports revenue, Q2 FY27Rs. 397 Cr
- API + CDMO capacity614 KL
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.